Table 1 General characteristics
Variables | Groups | Epilepsy | No epilepsy | Total | Univariate p-value | Multivariate p-value | Multivariate OR (95% CI) |
|---|---|---|---|---|---|---|---|
Gender | Female | 59 (12.16%) | 181 (37.32%) | 240 (49.48%) | Reference | - | - |
Male | 60 (12.37%) | 185 (38.14%) | 245 (50.52%) | 0.981 | - | - | |
Age (years) |  | 43.96 ± 16.98 | 54.28 ± 15.07 | 51.75 ± 16.18 | 0.000 | 0.000 | 0.99 (0.98–0.99) |
Location | Supratentorial | 117 (24.12%) | 332 (68.45%) | 449 (92.58%) | 0.006 | 0.000 | 1.36 (1.18–1.57) |
Subtentorial | 2 (0.41%) | 34 (7.01%) | 36 (7.42%) | Reference | Reference | Reference | |
Tumor number | Single | 110 (22.68%) | 331 (68.25%) | 441 (90.93%) | Reference | - | - |
Multiple | 9 (1.86%) | 35 (7.22%) | 44 (9.07%) | 0.510 | - | - | |
Admission status | KPS ≤ 70 | 15 (3.09%) | 70 (14.43%) | 85 (17.53%) | 0.105 | - | - |
KPS > 70 | 104 (21.44%) | 296 (61.03%) | 400 (82.47%) | Reference | - | - | |
Type | Primary | 106 (21.86%) | 320 (65.98%) | 426 (87.84%) | Reference | - | - |
Recurrent | 13 (2.68%) | 46 (9.48%) | 59 (12.16%) | 0.634 | - | - | |
WHO grade | I | 12 (2.47%) | 28 (5.77%) | 40 (8.25%) | 0.015 | 0.079 | 1.14 (0.98–1.33) |
II | 55 (11.34%) | 53 (10.93%) | 108 (22.27%) | 0.000 | 0.000 | 1.37 (1.24–1.50) | |
III | 19 (3.92%) | 68 (14.02%) | 87 (17.94%) | 0.087 | 0.072 | 1.10 (0.99–1.21) | |
IV | 33 (6.80%) | 217 (44.74%) | 250 (51.55%) | Reference | Reference | Reference | |
Total | Â | 119 (24.54%) | 366 (75.46%) | 485 | Â | Â | Â |